EBOS Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EBOSY research report →
Companywww.ebosgroup.com
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
- CEO
- Adam Luke Hall
- IPO
- 2017
- Employees
- 5,200
- HQ
- Docklands, VIC, AU
Price Chart
Valuation
- Market Cap
- $1.33B
- P/E
- 16.56
- P/S
- 0.24
- P/B
- 1.30
- EV/EBITDA
- 11.12
- Div Yield
- 5.96%
Profitability
- Gross Margin
- 10.29%
- Op Margin
- 2.45%
- Net Margin
- 1.43%
- ROE
- 8.16%
- ROIC
- 5.59%
Growth & Income
- Revenue
- $13.21B · -8.34%
- Net Income
- $231.66M · -21.93%
- EPS
- $4.72 · -23.62%
- Op Income
- $455.58M
- FCF YoY
- 37.55%
Performance & Tape
- 52W High
- $46.64
- 52W Low
- $24.13
- 50D MA
- $31.52
- 200D MA
- $36.08
- Beta
- 0.20
- Avg Volume
- 99
Get TickerSpark's AI analysis on EBOSY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EBOSY Coverage
We haven't published any research on EBOSY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EBOSY Report →